oxazolidin-2-one has been researched along with Myocardial Infarction in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angermann, C; Armitage, J; Baigent, C; Barter, P; Baxter, A; Blaustein, R; Bowman, L; Braunwald, E; Brenner, S; Cannon, C; Chen, F; Chen, Y; Chen, Z; Collins, R; Dayanandan, R; DeLucca, P; Ertl, G; Fabbri, G; Fajardo-Moser, M; Goodenough, R; Goto, S; Gray, A; Hao, D; Haynes, R; Herrington, W; Hill, M; Hopewell, JC; Knott, C; Landray, M; Lay, M; Liu, J; Lucci, D; Macdonnell, S; Maggioni, A; Mihaylova, B; Mitchel, Y; Mosegaard, S; Murphy, K; Sammons, E; Stevens, W; Tobert, J; Valdes-Marquez, E; Wallendszus, K; Wanner, C; Wincott, E; Wiviott, S; Wuhan, B; Zhang, H | 1 |
| Francis, DP; Keene, D; Price, C; Shun-Shin, MJ | 1 |
| Anttonen, O; Ekström, K; Lönnberg, A | 1 |
| Acikel, S; Akdemir, R; Dogan, M; Kilic, H; Sari, M | 1 |
| Mitka, M | 1 |
| Golwala, H; Lozano, P; Smith, M | 1 |
| Batista, A; Carvalho, S; Ferreira, A; Ferreira, C; Linhares, F; Margato, R; Mateus, P; Moreira, I; Ribeiro, H | 1 |
| Petro, DJ | 1 |
| Airoldi, F; Colombo, A; Mikhail, GW | 1 |
| Galbut, BH; Galbut, EJ; Kavinsky, CJ; McMullan, PW; Pacheco-Coronado, R; Schaer, GL; Snell, J | 1 |
2 review(s) available for oxazolidin-2-one and Myocardial Infarction
| Article | Year |
|---|---|
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.
Topics: Amides; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Coronary Disease; Esters; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, HDL; Myocardial Infarction; Niacin; Oxazolidinones; Quinolines; Randomized Controlled Trials as Topic; Stroke; Sulfhydryl Compounds | 2014 |
Myocardial infarction after taking zolmitriptan.
Topics: Aged; Coronary Artery Disease; Female; Humans; Migraine Disorders; Myocardial Infarction; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines | 2005 |
1 trial(s) available for oxazolidin-2-one and Myocardial Infarction
| Article | Year |
|---|---|
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.
Topics: Adult; Atherosclerosis; Atorvastatin; Double-Blind Method; Humans; Myocardial Infarction; Oxazolidinones; Treatment Outcome | 2022 |
7 other study(ies) available for oxazolidin-2-one and Myocardial Infarction
| Article | Year |
|---|---|
[Myocardial infarction in a patient free of coronary artery disease].
Topics: Humans; Myocardial Infarction; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2016 |
Prinzmetal-variant angina in a patient using zolmitriptan and citalopram.
Topics: Angina Pectoris, Variant; Citalopram; Coronary Angiography; Coronary Vasospasm; Drug Therapy, Combination; Electrocardiography; Female; Humans; Middle Aged; Myocardial Infarction; Oxazolidinones; Serotonin Agents; Tryptamines | 2010 |
CETP inhibition shows promise as way to reduce cardiovascular disease risk.
Topics: Aged; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Revascularization; Oxazolidinones; Randomized Controlled Trials as Topic; Risk | 2011 |
Zolmitriptan induced acute coronary syndrome: a unique case.
Topics: Acute Coronary Syndrome; Chest Pain; Electrocardiography; Humans; Male; Middle Aged; Migraine Disorders; Myocardial Infarction; Nitroglycerin; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines; Vasodilator Agents | 2011 |
[Myocardial infarction after taking zolmitriptan].
Topics: Aged; Humans; Male; Myocardial Infarction; Oxazolidinones; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2012 |
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
Topics: Antidepressive Agents; Brain; Cerebrovascular Circulation; Dietary Supplements; Drug and Narcotic Control; Ephedrine; Humans; Hypertension; Myocardial Infarction; Oxazolidinones; Risk; Serotonin Agents; Stroke; Sumatriptan; Syndrome; Tryptamines; Vasoconstriction | 2002 |
Acute myocardial infarction following the use of antimigraine therapy.
Topics: Female; Humans; Middle Aged; Myocardial Infarction; Oxazolidinones; Plasminogen Activators; Serotonin Receptor Agonists; Thrombolytic Therapy; Tissue Plasminogen Activator; Tryptamines | 2004 |